Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-25-004153
Filing Date
2025-02-13
Accepted
2025-02-13 07:30:33
Documents
70
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q ef20039004_10q.htm   iXBRL 10-Q 962117
7 EXHIBIT 10.1 ef20039004_ex10-1.htm EX-10.1 216215
8 EXHIBIT 10.2 ef20039004_ex10-2.htm EX-10.2 48234
9 EXHIBIT 10.3 ef20039004_ex10-3.htm EX-10.3 44449
10 EXHIBIT 31.1 ef20039004_ex31-1.htm EX-31.1 8730
11 EXHIBIT 31.2 ef20039004_ex31-2.htm EX-31.2 8670
12 EXHIBIT 32.1 ef20039004_ex32-1.htm EX-32.1 6100
13 EXHIBIT 32.2 ef20039004_ex32-2.htm EX-32.2 6001
14 image1.jpg GRAPHIC 97509
15 image2.jpg GRAPHIC 23269
16 image3.jpg GRAPHIC 40106
17 image4.jpg GRAPHIC 24669
18 image5.jpg GRAPHIC 47017
19 image6.jpg GRAPHIC 185927
20 image7.jpg GRAPHIC 59059
21 image8.jpg GRAPHIC 134786
  Complete submission text file 0001140361-25-004153.txt   6300861

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - CALCULATION LINKBASE DOCUMENT grce-20241231_cal.xml EX-101.CAL 27260
3 INLINE XBRL TAXONOMY EXTENSION - SCHEMA grce-20241231.xsd EX-101.SCH 30212
4 INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE grce-20241231_def.xml EX-101.DEF 166337
5 INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE grce-20241231_lab.xml EX-101.LAB 306353
6 INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE grce-20241231_pre.xml EX-101.PRE 177505
72 EXTRACTED XBRL INSTANCE DOCUMENT ef20039004_10q_htm.xml XML 516252
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-322-1602
Grace Therapeutics, Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35776 | Film No.: 25617216
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)